Lynn M. Schuchter: Looking forward to co-chairing Strategies for Detecting MRD and How to Apply It in the Clinic – AACR24 session with AACR President, Philip D. Greenberg

Lynn M. Schuchter shared a post by the American Association for Cancer Research on X/Twitter:

“Looking forward to co-chairing this AACR24 session with AACR President, Philip D. Greenberg. It’s important for the American Association for Cancer Research (AACR) and the American Society of Clinical Oncology (ASCO) to have joint sessions like this that bring together the basic and translational scientists and the practicing oncologists to address the pressing needs that face our patients with cancer.”

Quoting AACR’s post:

“Strategies for Detecting Minimal Residual Disease (MRD) and How to Apply It in the Clinic: AACR President, Philip D. Greenberg and ASCO President Lynn M. Schuchter will moderate this AACR-ASCO Joint Session on Monday, April 8, 4:45-6:15 PM at AACR24. Learn more.”

Source: Lynn M. Schuchter/X and AACR/X

Lynn M. Schuchter is the President of the American Society of Clinical Oncology (ASCO). Dr. Schuchter is the Chief of the Division of Hematology-Oncology at the Abramson Cancer Center at the University of Pennsylvania, Director of the Tara Miller Melanoma Center and Professor of Hematology-Oncology at the Perelman School of Medicine at the University of Pennsylvania. Dr. Schuchter served on the ASCO Board of Directors from 2009 to 2012, as well as several ASCO committees, including terms as Chair of the Annual Meeting Scientific Program Committee, Cancer Research Committee, and Cancer Communications Committee. In 2019, she was awarded ASCO’s Women Who Conquer Cancer Mentorship Award.